Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Journal of Cancer|November 12, 2021
CD33-directed immunotherapy with third-generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33-edited acute myeloid leukemia and hematopoietic stem and progenitor cellsYi Liu, Sanmei Wang, Maria-Luisa Schubert, et al.
Leukemia|July 16, 2026
Dose-reduced (24 Gy) involved-site radiotherapy combined with rituximab in early-stage non-gastric mucosa-associated lymphoid tissue lymphoma: a prospective phase II trialHailing Liu, Yuexin Cheng, Shu Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 4, 2026
CD96 as a Therapeutic Target for CAR T-Cell Therapy in Acute Myeloid LeukemiaXiaotong Gao, Hailing Liu, Guokun Li, et al.
Frontiers in Immunology|December 28, 2020
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T CellsMingya Yang, Lei Wang, Ming Ni, et al.
Frontiers in Immunology|June 14, 2021
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell ImmunotherapyMingya Yang, Lei Wang, Ming Ni, et al.
Cytotherapy|October 29, 2021
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cellsMing Ni, Lei Wang, Yuntian Ding, et al.
Pediatric Investigation|June 20, 2025
Effectiveness and safety of perampanel for pediatric patients with epilepsy: A real-world study from ChinaXiaohui Wang, Taoyun Ji, Maomao Liu, et al.
International Journal of Cancer|February 10, 2019
Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patientsSophia Stock, Rudolf Übelhart, Maria-Luisa Schubert, et al.
Pageof 3